One page, thousands of outlets. See who else covered it.
Don't be surprised if you start hearing some more coughing in the next few weeks. COVID-19 is once again on the rise in nearly every corner of the U.S.
We haven't written up this one. The Hill has the full story — the link below goes straight to it.
(MedPage Today) -- A consumer watchdog group is demanding that the HHS Office of Inspector General (OIG) look into potential conflicts of interest among members of an FDA advisory committee that…
A new stem cell treatment for ARK (aniridia-related keratopathy) improved patients' vision in a first-in-human clinical trial for this previously untreatable rare genetic eye condition at Moorfields…
(MedPage Today) -- The resident was apologetic over the phone, embarrassed for reasons outside his control. He was transferring, from his hospital to ours, a pregnant patient who required consultation…
Officials warn they are continuing to identify new chains of transmission, which need to be broken to stop the spread.
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built NEW YORK, Aug.
At a Walgreens in San Francisco's bustling Japantown neighborhood, pharmacist Margaret On stocks two boxes of long-acting insulin pens from California's new prescription drug label, CalRx, emblazoned…
